Research Overview: Clomigen Citrate 50mg
Clomigen Citrate 50mg is a selective estrogen receptor modulator (SERM) manufactured by Calvin Scott for advanced laboratory research applications. This pharmaceutical-grade compound demonstrates selective antagonistic and agonistic properties across different tissue types, making it invaluable for post-cycle therapy investigations. Researchers examining hormonal recovery mechanisms frequently utilise this compound to investigate endogenous testosterone restoration pathways and hypothalamic-pituitary-gonadal axis functionality. The compound’s molecular structure enables researchers to study estrogen receptor binding affinity variations across different tissue systems. Our Stroid UK Shop maintains stringent quality standards ensuring consistent research outcomes.
Laboratory Applications
Research scientists investigate Clomigen Citrate’s mechanism of action in blocking estrogen receptors within hypothalamic tissue while simultaneously activating estrogen receptors in hepatic tissue. Studies examine how this selective modulation influences luteinising hormone and follicle-stimulating hormone secretion patterns. Comparative research with compounds available through our post cycle therapy category demonstrates varying efficacy profiles across different SERM classifications. Researchers analyse dose-response relationships and temporal kinetics when examining hormonal recovery protocols. Advanced studies investigate potential synergistic effects when combined with other research compounds from our SARMs and peptides collections for comprehensive research methodologies.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Clomifene Citrate |
| Concentration | 50mg per tablet |
| Quantity | 100 tablets |
| Manufacturer | Calvin Scott |
| CAS Number | 50-41-9 |
| Molecular Formula | C₂₆H₂₈ClNO·C₆H₈O₇ |
| Molecular Weight | 598.09 g/mol |
| Storage | Cool, dry conditions |
Research Compliance
This product is manufactured exclusively for in-vitro research purposes and is not intended for human consumption, therapeutic use, or any diagnostic applications. Researchers must possess appropriate laboratory facilities and qualifications before conducting studies with this compound.

